{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T05:19:12Z","timestamp":1722057552928},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00120-016-0275-2","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T09:04:18Z","timestamp":1479978258000},"page":"18-23","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["\u201ePSMA-radioguided surgery\u201c beim lokal begrenzten Prostatakarzinomrezidiv"],"prefix":"10.1007","volume":"56","author":[{"given":"I.","family":"Rauscher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Eiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Jilg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"issue":"1","key":"275_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z et\u00a0al (2014) Cancer statistics, 2014. CA Cancer J Clin 64(1):9\u201329","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"275_CR2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","volume":"59","author":"SA Boorjian","year":"2011","unstructured":"Boorjian SA, Thompson RH, Tollefson MK et al (2011) Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 59(6):893\u2013899","journal-title":"Eur Urol"},{"issue":"1","key":"275_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2013.04.019","volume":"64","author":"MH Umbehr","year":"2013","unstructured":"Umbehr MH, Muntener M, Hany T et al (2013) The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET\/CT in prostate cancer: a\u00a0systematic review and meta-analysis. Eur Urol 64(1):106\u2013117","journal-title":"Eur Urol"},{"issue":"4","key":"275_CR4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/bc200279b","volume":"23","author":"M Eder","year":"2012","unstructured":"Eder M, Schafer M, Bauder-Wust U et al (2012) 68\u202fGa-complex lipophilicity and the targeting property of a\u00a0urea-based PSMA inhibitor for PET imaging. Bioconjug Chem 23(4):688\u2013697","journal-title":"Bioconjug Chem"},{"issue":"1","key":"275_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","volume":"41","author":"A Afshar-Oromieh","year":"2014","unstructured":"Afshar-Oromieh A, Zechmann CM, Malcher A et al (2014) Comparison of PET imaging with a\u00a0(68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer. Eur J Nucl Med Mol Imaging 41(1):11\u201320","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"275_CR6","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M et al (2015) Evaluation of hybrid (6)(8)ga-PSMA Ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med 56(5):668\u2013674","journal-title":"J Nucl Med"},{"issue":"8","key":"275_CR7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2967\/jnumed.115.160382","volume":"56","author":"JJ Morigi","year":"2015","unstructured":"Morigi JJ, Stricker PD, van Leeuwen PJ et al (2015) Prospective comparison of 18F-fluoromethylcholine versus 68\u202fga-PSMA PET\/CT in prostate cancer patients who have rising PSA after curative treatment and are being considered for targeted therapy. J Nucl Med 56(8):1185\u20131190","journal-title":"J Nucl Med"},{"issue":"2","key":"275_CR8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eururo.2014.02.011","volume":"67","author":"N Suardi","year":"2015","unstructured":"Suardi N, Gandaglia G, Gallina A et al (2015) Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a\u00a0single-institution series with a\u00a0minimum follow-up of 5 years. Eur Urol 67(2):299\u2013309","journal-title":"Eur Urol"},{"issue":"5","key":"275_CR9","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.eururo.2014.03.019","volume":"67","author":"F Abdollah","year":"2015","unstructured":"Abdollah F, Briganti A, Montorsi F et\u00a0al (2015) Contemporary role of salvage lymphadenectomy in patients with recurrence following radical prostatectomy. Eur Urol 67(5):839\u2013849","journal-title":"Eur Urol"},{"issue":"1","key":"275_CR10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13550-015-0147-6","volume":"5","author":"M Schottelius","year":"2015","unstructured":"Schottelius M, Wirtz M, Eiber M et al (2015) [(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery. EJNMMI Res 5(1):68","journal-title":"EJNMMI Res"},{"issue":"3","key":"275_CR11","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.eururo.2015.04.034","volume":"68","author":"T Maurer","year":"2015","unstructured":"Maurer T, Weirich G, Schottelius M et al (2015) Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. Eur Urol 68(3):530\u2013534","journal-title":"Eur Urol"},{"issue":"5","key":"275_CR12","doi-asserted-by":"crossref","first-page":"e549","DOI":"10.1016\/j.clgc.2016.05.020","volume":"14","author":"T Maurer","year":"2016","unstructured":"Maurer T, Schwamborn K, Schottelius M et\u00a0al (2016) PSMA Theranostics Using PET and Subsequent Radioguided Surgery in Recurrent Prostate Cancer. Clin Genitourin Cancer 14(5):e549\u2013e552","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"275_CR13","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1097\/RLU.0000000000001273","volume":"41","author":"I Rauscher","year":"2016","unstructured":"Rauscher I, Maurer T, Souvatzoglou M et al (2016) Intrapatient comparison of 111in-PSMA I&T SPECT\/CT and hybrid 68\u202fga-HBED-CC PSMA PET in patients with early recurrent prostate cancer. Clin Nucl Med 41(9):e397\u2013e402","journal-title":"Clin Nucl Med"},{"key":"275_CR14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.178939","author":"S Robu","year":"2016","unstructured":"Robu S, Schottelius M, Eiber M et al (2016) Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer. J Nucl Med. doi: 10.2967\/jnumed.116.178939","journal-title":"J Nucl Med"},{"issue":"5","key":"275_CR15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","volume":"60","author":"P Rigatti","year":"2011","unstructured":"Rigatti P, Suardi N, Briganti A et\u00a0al (2011) Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography. Eur Urol 60(5):935\u2013943","journal-title":"Eur Urol"},{"issue":"2","key":"275_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eururo.2014.02.011","volume":"67","author":"N Suardi","year":"2015","unstructured":"Suardi N, Gandaglia G, Gallina A et al (2015) Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a\u00a0single-institution series with a\u00a0minimum follow-up of 5 years. Eur Urol 67(2):299\u2013309","journal-title":"Eur Urol"},{"issue":"6","key":"275_CR17","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.juro.2012.08.041","volume":"188","author":"CA Jilg","year":"2012","unstructured":"Jilg CA, Rischke HC, Reske SN et\u00a0al (2012) Salvage lymph node dissection with adjuvant radiotherapy for nodal recurrence of prostate cancer. J\u00a0Urol 188(6):2190\u20132197","journal-title":"J Urol"},{"issue":"4","key":"275_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00066-014-0763-5","volume":"191","author":"HC Rischke","year":"2015","unstructured":"Rischke HC, Schultze-Seemann W, Wieser G et al (2015) Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only. Strahlenther Onkol 191(4):310\u2013320","journal-title":"Strahlenther Onkol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-016-0275-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0275-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T22:55:10Z","timestamp":1568588110000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-016-0275-2"}},"subtitle":["Aktueller Stand und zuk\u00fcnftige Entwicklungen"],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1007\/s00120-016-0275-2","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}